Articles, guides, and regulatory updates from our community.
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy by reducing oxidative stress.
By Peptide Association Research Team
New research explores how mitochondria-targeted peptide nanoparticles may protect the liver from ischemia-reperfusion injury. Learn what the science shows.
By Peptide Association Research Team
A 2026 ACS Nano study suggests mitochondria-targeted nanoparticles may reduce liver ischemia-reperfusion injury by limiting ROS and inflammation in mice.
By Peptide Association Research Team
New research explores how mitochondria-targeted polydopamine nanoparticles modified with SS-31 peptide may protect the liver from ischemia-reperfusion injury.
By Peptide Association Research Team
Recent research explores mitochondrial-targeted liposomes containing SS-31 peptide for obesity treatment. Study shows improved fat metabolism in animal models.
By Peptide Association Research Team
Breakthrough study reveals how SS-31 peptide and targeted liposomes may enhance fat burning by improving mitochondrial function in adipose tissue.
By Peptide Association Research Team
New research on mitochondria-targeted liposomes with SS-31 peptide demonstrates potential for enhancing thermogenesis in adipose tissue studies.
By Peptide Association Research Team